Maryam Hami; Mehrdad Sarabi; Mehdi Hassanzade Daloee; Hassan Mehrad-Majd; Abdollah Firoozi; Niloofar Nourizadeh; Niloofar Nikpasand; Sara Naghizadeh Kashani; Mina AkbariRad
Abstract
Background and aim: Cardiac arrhythmia is common in end-stage renal disease (ESRD) patients, especially those undergoing hemodialysis. One of the most significant risk factors for cardiac arrhythmias is thought to be electrolytic abnormalities. This study aimed to assess the effect of hemodialysis on ...
Read More
Background and aim: Cardiac arrhythmia is common in end-stage renal disease (ESRD) patients, especially those undergoing hemodialysis. One of the most significant risk factors for cardiac arrhythmias is thought to be electrolytic abnormalities. This study aimed to assess the effect of hemodialysis on cardiac arrhythmias according to electrolytic disorders in chronic kidney disease (CKD) patients.Materials and methods: This cross-sectional study was conducted on ESRD patients who had undergone hemodialysis for at least six months. An electrocardiogram (ECG) and serum levels of sodium, potassium, calcium, and magnesium were checked before and after hemodialysis for all the patients. The data were entered and analyzed using SPSS software.Results: In this study, 96 patients were included. The most common arrhythmia was atrial fibrillation (AF) (22.9%). Our findings revealed that changes in serum potassium levels (p = 0.036) had a significant relationship with the occurrence of AF. There was a significant negative relationship between changes in serum calcium level and the QTc interval (r = -0.223 and p = 0.023). Furthermore, there was a significant positive relationship between changes in serum calcium levels and the QRS complex amplitude (r = 0.350 and p = 0.0001).Conclusion: ECG abnormalities, especially AF arrhythmias, are common in patients undergoing hemodialysis, which highlights the need for ECG monitoring both during and after hemodialysis.
Behnaz Hatami; Omid Shoraka; Asef Younesi; Gelayol Bavafa; Melika Zamanian; Niloofar Nikpasand; Amirhossein Mohammadzade; Sara Naghizadeh Kashani; Anoush Azarfar; Mojtaba Yousefi Zoshk
Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a novel syndrome in children following the coronavirus disease 2019 (COVID-19) pandemic, which has similar symptoms to Kawasaki disease or toxic shock syndrome. The most prevalent symptoms in MIS-C patients are fever and gastrointestinal symptoms, ...
Read More
Multisystem inflammatory syndrome in children (MIS-C) is a novel syndrome in children following the coronavirus disease 2019 (COVID-19) pandemic, which has similar symptoms to Kawasaki disease or toxic shock syndrome. The most prevalent symptoms in MIS-C patients are fever and gastrointestinal symptoms, with substantial cardiac complications. Cardiac involvement is frequently reported in MIS-C patients and includes arrhythmia, coronary artery aneurysm and dilation, conduction abnormalities, and ventricular dysfunction. Cardiogenic or vasodilatory shock may develop in patients with severe MIS-C, necessitating inotropic support, fluid resuscitation, mechanical ventilation, and extracorporeal membrane oxygenation. Empirical therapies have attempted to reverse the inflammatory response, and steroids or intravenous immunoglobulin have all been commonly used. Most children will survive with prompt diagnosis and appropriate treatment, but since the disease's outcomes are unclear, long-term follow-ups are necessary. This narrative review summarizes the available studies regarding cardiac involvement in MIS-C cases as well as clinical considerations for cardiac examination and follow-up.